A novel personalized vaccine made using patients’ tumor tissue and immune cells stimulates potent therapeutic immune responses, extending overall survival of patients with recurrent ovarian cancer
To date, gene expression in tumors has been typically profiled by capturing messenger RNAs; however, they represent only a fraction of the molecules detected